These findings suggest that circadian-timed bromocriptine administration may influence MBH neuronal plasticity in a manner that associates with ameliorated overexpression of AgRP and NPY to improve metabolism in high fat diet-induced metabolic syndrome. This evidence concerns the gene NPY and metabolic syndrome.